Directory › Recipharm

Recipharm — Uppsala

Uppsala, Sweden · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Recipharm
Name(s) in FDA data
Recipharm Uppsala AB
FEI number(s)
1000171246 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Uppsala, Sweden
Records matched
4 FDA inspections · 1 inspection with posted 483 citations
Most recent FDA inspection in dataset
17 Apr 2024 — VAI

Capabilities (from the company's website)

  • API / drug substance (chemical)
    …in Recipharm’s European CDMO network. Located in Uppsala, Sweden, the site specialises in API production and the manufacture of oral solid and suppository dosage forms. The facility s…
  • Oral solid dose
    …Located in Uppsala, Sweden, the site specialises in API production and the manufacture of oral solid and suppository dosage forms. The facility supports customers worldwide with high-quality…
  • Oral liquids & semi-solids
    …the full product lifecycle: Oral solid dose services Packaging and serialization services Semi-solid production Regulatory Quality, Compliance, and Regulatory Readiness Global regulatory app…
  • Clinical trial supply & packaging
    …redients (API) production Coated and uncoated tablets Suppositories Integrated operations Packaging and bulk product handling Bottling and serialisation Manual aggregation processes EU rele…

Taken from the company's web page for this site. Source: https://www.recipharm.com/about-us/locations/uppsala, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 17 Apr 2024
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1000171246, inspection ID 1301930)

  2. 26 Aug 2021
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1000171246, inspection ID 1210857)

  3. 30 Jun 2017
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1000171246, inspection ID 1028387)

  4. 14 Mar 2014
    Form 483 observations 1 posted Form 483 citation(s)

    Citation summaries (1)
    • 21 CFR 211.101(d): Component addition checked by 2nd person

    Source: FDA Data Dashboard – Citations (FEI 1000171246, inspection ID 869566)

  5. 14 Mar 2014
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1000171246, inspection ID 869566)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.